A recent crystal structure of the N15 ␣ր␤ -T cell receptor (TCR) in complex with an Fab derived from the H57 C ␤ -specific monoclonal antibody (mAb) shows the mAb fragment interacting with the elongated FG loop of the C ␤ domain. This loop creates one side wall of a cavity within the TCR Ti-␣ր␤ constant region module (C ␣ C ␤ ) while the CD and EF loops of the C ␣ domain form another wall. The cavity size is sufficient to accommodate a single nonglycosylated Ig domain such as the CD3 ⑀ ectodomain. By using specific mAbs to mouse TCR-␤ (H57) and CD3 ⑀ (2C11) subunits, we herein provide evidence that only one of the two CD3 ⑀ chains within the TCR complex is located in close proximity to the TCR C ␤ FG loop, in support of the above notion. Moreover, analysis of T cells isolated from transgenic mice expressing both human and mouse CD3 ⑀ genes shows that the heterologous human CD3 ⑀ component can replace the mouse CD3 ⑀ at this site. The location of one CD3 ⑀ subunit within the rigid constant domain module has implications for the mechanism of signal transduction throughout T cell development. E ach TCR consists of a clonotypic TCR heterodimer (Ti-␣ր␤ or Ti-␥ր␦ subunits) in complex with the invariant CD3 chains ( ␥ , ␦ , ⑀ , and ). The disulfide-linked heterodimer represents the peptide-MHC ligand binding unit, thereby determining the ligand specificity of an individual T cell. In contrast, the CD3 polypeptides which are in noncovalent association with a given Ti heterodimer, mediate TCR-base signal transduction (for review see references 1-5). Although CD3-␥ and -␦ are present in only one copy each (6-8), it appears that two copies of CD3 ⑀ and exist per TCR complex (9-11). The signaling function of the CD3 components involves a conserved motif, termed an immunoreceptor tyrosine-based activation motif (ITAM) present in one to three copies in the cytoplasmic domain of each CD3 subunit (12, 13). The various CD3 subunits exhibit different interactions with intracellular signaling factors and induce distinct patterns of cellular protein tyrosine phosphorylation upon activation (14-19). How peptide-MHC ligand binding to a Ti-␣ր␤ or Ti-␥ր␦ heterodimer subsequently initiates signaling via the CD3 molecules is currently unknown.
Summary
A recent crystal structure of the N15 ␣ր␤ -T cell receptor (TCR) in complex with an Fab derived from the H57 C ␤ -specific monoclonal antibody (mAb) shows the mAb fragment interacting with the elongated FG loop of the C ␤ domain. This loop creates one side wall of a cavity within the TCR Ti-␣ր␤ constant region module (C ␣ C ␤ ) while the CD and EF loops of the C ␣ domain form another wall. The cavity size is sufficient to accommodate a single nonglycosylated Ig domain such as the CD3 ⑀ ectodomain. By using specific mAbs to mouse TCR-␤ (H57) and CD3 ⑀ (2C11) subunits, we herein provide evidence that only one of the two CD3 ⑀ chains within the TCR complex is located in close proximity to the TCR C ␤ FG loop, in support of the above notion. Moreover, analysis of T cells isolated from transgenic mice expressing both human and mouse CD3 ⑀ genes shows that the heterologous human CD3 ⑀ component can replace the mouse CD3 ⑀ at this site. The location of one CD3 ⑀ subunit within the rigid constant domain module has implications for the mechanism of signal transduction throughout T cell development. E ach TCR consists of a clonotypic TCR heterodimer (Ti-␣ր␤ or Ti-␥ր␦ subunits) in complex with the invariant CD3 chains ( ␥ , ␦ , ⑀ , and ). The disulfide-linked heterodimer represents the peptide-MHC ligand binding unit, thereby determining the ligand specificity of an individual T cell. In contrast, the CD3 polypeptides which are in noncovalent association with a given Ti heterodimer, mediate TCR-base signal transduction (for review see references [1] [2] [3] [4] [5] . Although CD3-␥ and -␦ are present in only one copy each (6) (7) (8) , it appears that two copies of CD3 ⑀ and exist per TCR complex (9) (10) (11) . The signaling function of the CD3 components involves a conserved motif, termed an immunoreceptor tyrosine-based activation motif (ITAM) present in one to three copies in the cytoplasmic domain of each CD3 subunit (12, 13) . The various CD3 subunits exhibit different interactions with intracellular signaling factors and induce distinct patterns of cellular protein tyrosine phosphorylation upon activation (14) (15) (16) (17) (18) (19) . How peptide-MHC ligand binding to a Ti-␣ր␤ or Ti-␥ր␦ heterodimer subsequently initiates signaling via the CD3 molecules is currently unknown.
Aside from their role in signal transduction, the CD3 subunits are also required for cell surface expression of the TCR heterodimers on mature T lymphocytes (20, 21) , as well as for pre-T cell receptor function on immature CD4 Ϫ CD8 Ϫ double negative (DN) 1 thymocytes (22, 23) . Thus, without CD3 ⑀ or -subunit expression there is a marked decrease or absence of TCR molecules on the cell surface as shown by in vitro analysis (20, 21, 24) . In addition, in genetically engineered mouse strains in which these CD3 components are deleted by homologous recombination, there is a developmental blockade of thymocytes at the DN stage (25) (26) (27) (28) (29) . The CD3 ␦ subunit, in contrast to CD3 ⑀ and -chains, is required for TCR expression only at a later stage of thymic development. The absence of CD3 ␦ in a knockout mouse specifically blocks the thymic selection processes mediating the transition from double positive (DP) (CD4 ϩ CD8 ϩ ) to single positive (CD4 ϩ CD8 Ϫ or CD4 Ϫ CD8 ϩ ) thymocytes (30) .
Although the overall stoichiometry of the TCR complex is commonly given as TCR-␣ր␤ -CD3 ␥ր␦ր⑀ 2 ր 2 , there is no direct structural evidence to support this subunit composition. Recently, a three-dimensional structure of the N15 vesicular stomatitis virus-specific/H-2K b -restricted ␣ր␤ -TCR (31) in complex with an Fab fragment from the 1530 T Cell Receptor Subunit Topology H57 anti-mouse C ␤ -specific mAb (32) provided a clue with which to infer new details about the association between the TCR-␣ր␤ heterodimer and CD3 ⑀ (33) . We identified a cavity within the TCR-␣ / ␤ C module formed by the C ␤ FG loop, partially exposed C ␤ domain strands, and conserved glycans from both C ␣ and C ␤ domains that can accommodate a single Ig-like domain. Based on size and charge considerations, we suggested that the cavity probably represents the CD3 ⑀ binding site. To determine whether there is a physical proximity between the C ␤ FG loop and the CD3 ⑀ chain, we performed a set of competition assays between the H57 and the CD3 ⑀ -specific 2C11 mAbs (34) . The results of these experiments provide evidence that one of the two CD3 ⑀ subunits in a TCR complex is physically adjacent to the TCR-␤ constant region FG loop.
Materials and Methods
Transgenic Mice. Transgenic mice expressing the human CD3 ⑀ gene (transgenic [tg] 600; reference 35) were provided by Dr. Cox Terhorst (Beth Israel Medical Center, Boston, MA) and are further referred to as hCD3 ⑀ tg. This transgenic mouse strain contains 10-12 copies of the human CD3 ⑀ transgene in a hemizygous mouse. Since T cell development is blocked in the homozygous mice of this strain, we used hCD3 ⑀ tg heterozygous mice for these studies. A littermate that does not contain the human CD3 ⑀ transgene was used as a control (wild-type, WT).
Molecular Modeling of the N15 TCR-H57 Fab Complex. The molecular modeling was produced using the N15 TCR and H57 Fab complex crystal structure 3D coordinates (PDB code 1NFD; 33). The plot of the protein structure was created using the programs MOLSCRIPT (36) and RASTER3D (37) .
Flow Cytometric Analysis. The following mAbs were used: R-PE-labeled anti-mouse CD3 ⑀ (500A2; PharMingen, San Diego, CA), PE-labeled anti-mouse CD4 (H129.19; GIBCO BRL, Gaithersburg, MD), and Red613-labeled anti-mouse CD8 (53-6.7; GIBCO BRL). The mAbs hamster anti-mouse TCR-␤ (H57-597; reference 32), hamster anti-mouse CD3 ⑀ (2C11-145; reference 34), and mouse anti-mouse V ␤ 8.1,2,3 (F23.1; reference 38) were purified and labeled with FITC using the FluoReporter ® FITC protein-labeling kit (Molecular Probes, Eugene, OR). Generation and purification of 2C11 and H57 Fab fragments were performed by using the ImmunoPure Fab Preparation Kit (Pierce, Rockford, IL). The purity of the Fab fragments was confirmed by SDS-PAGE, which demonstrated no residual intact IgG. Splenocytes from nontransgenic mice (WT) or mice heterozygous for human CD3 ⑀ (hCD3 ⑀ tg) were triple stained as follows: cells were incubated with PE-labeled anti-CD4, Red613-labeled anti-CD8, and FITC-H57 or FITC-2C11 for 30 min at 4 Њ C in PBS containing 2% FCS. For mAb competition assays, splenocytes were first incubated with unlabeled H57 or 2C11 mAbs at 10-fold molar excess of the FITC-labeled mAb for 30 min at 4 Њ C, washed with PBS ϩ 2% FCS, and triple stained as explained above. Flow cytometric analysis was performed on a FACScan (Becton Dickinson, San Jose, CA). Samples were gated on live cells based on forward and side scatter parameters. Data (10,000 events per sample) were collected in list mode using FACScan Research software and analyzed using LYSYS II software (Becton Dickinson). The mean fluorescence intensity (mFI) of the FITC-labeled H57 or FITC-labeled 2C11 labeled T cells (CD4 ϩ or CD8 ϩ splenocytes) was measured and the FITC mFI of non-T cell splenocytes (CD4 Ϫ or CD8 Ϫ ; background) was deducted from this value in each sample.
Results
A TCR Constant Domain Module Cavity as a Putative CD3 ⑀ Binding Site. The three-dimensional structure of a complex between the N15 ␣ր␤ -TCR and the anti-TCR-␤ chain mAb H57 Fab fragment resolved crystallographically to 2.8Å has revealed several interesting features about TCR structure relative to antibody structure. As shown in Fig. 1 , there is an obvious difference between the ligand binding surface of the V domain modules of the two receptors (V ␣ V ␤ versus V h V l ), with a relatively flat antigen binding surface in the case of the TCR, versus a concave surface in the case of the Fab. The flatness of the N15 antigen binding surface and the concavity of the H57 Fab surface are complementary to the surface of their respective ligands, K b and C ␤ . Perhaps the most striking difference between these immunoreceptors is the symmetry of the Fab molecule compared with asymmetry of the TCR molecule. This TCR asymmetry results from the unusual arrangement of the C ␣ and C ␤ domains relative to one another. Moreover, as shown in Fig. 1 , the H57 Fab binds to the 12-residue C ␤ FG loop conserved among TCR C ␤ domains from multiple species (39) . This loop architecture is uniquely rigidified by a hydrophobic minicore and an internal hydrogen bonding network. In addition, we have noted that this loop creates one side wall of a cavity, while the CD and EF loops of the C␣ domain form the other side. The floor of the cave, which measures ‫52ف‬Å in depth, ‫02ف‬Å in height, and ‫52ف‬Å in width, is presumably formed by the plasma membrane on the T cell surface. The murine CD3⑀ subunit, which is predicted to have an Ig fold (40) , is nonglycosylated unlike CD3␥ and CD3␦, and could readily fit into a cavity of this size.
Nonreciprocal Cross-blocking of 2C11 and H57 mAbs. To investigate our hypothesis that a CD3⑀ subunit might occupy this cavity within the C module and hence lie proximal to the C␤ FG loop, a set of competition assays between the H57 and 2C11 mAbs were performed using direct immunofluorescence analysis by FACS ® . 2C11 was previously shown to specifically bind to the mouse CD3⑀ subunit (34) . As shown in Fig. 2 A, unlabeled competitor 2C11 or H57 was added before the addition of FITC-2C11, FITC-H57, or FITC-labeled anti-CD4, and log fluorescence was determined by quantitative FACS ® analysis. As expected, unlabeled 2C11 blocks the subsequent binding of FITC-2C11 and, likewise, unlabeled H57 blocks the binding of FITC-H57. In contrast, neither unlabeled 2C11 nor H57 alters the binding of the unrelated FITC-H129. 19 . More importantly, note that under these conditions the anti-CD3⑀ mAb completely blocks the binding of FITC-H57 mAb, whereas H57 only partially reduces the mFI of FITC-2C11 binding to CD3⑀ on mouse splenic T cells. A second anti-CD3⑀ mAb, 500A2, also completely blocked FITC-H57 binding and, as with FITC-2C11, the binding of PE-500A2 was reduced by 50% when T cells were preincubated with unlabeled H57 (data not shown). Moreover, similar results were obtained by using 2C11 Fab or H57 Fab fragments for inhibition analysis. That the findings are not secondary to "general" steric blockade of the TCR by any mAb or Fab fragment binding to the complex is evident from the inability of V␤-specific antibodies to block FITC-H57 binding on TCR transgenic T lymphocytes (data not shown).
Only One of the Two CD3⑀ Subunits Is Proximal to the C␤ FG Loop. To quantify the mFI reduction in FITC-2C11 resulting from unlabeled H57 preincubation in individual CD4 and CD8 T cell subsets, we performed the analogous competition experiments by three-color analysis, in addition using PE-labeled anti-mouse CD4 and Red613-labeled anti-mouse CD8. We collected data comparable to that shown in Fig. 2 A but on individual splenic CD4 ϩ and CD8 ϩ T lymphocytes. As shown in Fig. 2 B (left) for CD4 ϩ T cells, although unlabeled 2C11 completely blocked the binding of FITC-2C11 to the mouse T cells, the unlabeled H57 mAb reduced the binding of the FITC-2C11 by ‫%05ف‬ (mFI, from 402 to 183). On the other hand, unlabeled 2C11 almost completely blocked the binding of FITC-H57 (mFI, from 398 to 45; Fig. 2 B, right) . Identical results were obtained when CD8 ϩ T cells subset were examined. Three conclusions may be drawn from these data. First, one CD3⑀ subunit is close to the H57 mAb binding site on the C␤ FG loop. Second, given that there are two CD3⑀ components per TCR (10, 11) and the H57 mAb can only block 50% of the FITC-2C11 binding, the second CD3⑀ subunit must exist at a distance from the C␤ FG loop. Third, this postulated TCR subunit arrangement is found in both CD4 ϩ and CD8 ϩ T cell subpopulations.
The Human CD3⑀ Subunit as well as the Mouse CD3⑀ Subunit Associates with the C␣C␤ Module. To test whether replacement of the murine CD3⑀ chain with the human CD3⑀ subunit might alter the binding affinity of the H57 mAb to the C␤ FG epitope, we used a well-characterized transgenic mouse strain (tg 600) engineered to express the human CD3⑀ component (reference 35; here referred to as hCD3⑀tg). Splenocytes from littermates that do not express the human CD3⑀ (WT), as well as a heterozygous hCD3⑀tg mouse, were stained with directly labeled FITC-2C11 mAb at concentrations ranging from 5 ϫ 10 Ϫ6 -10 Ϫ10 M. As shown in Fig. 3 A, the hCD3⑀tg mouse expressed only Figure 1 . Model of the N15 ␣ր␤-TCR heterodimer complexed with the H57 anti-TCR C␤-specific mAb Fab fragment. Based on x ray coordinates and molecular modeling as described in Materials and Methods, a structure of the complex is shown. The TCR-␣ chain is in green, the TCR-␤ chain is in red, the H57 Fab heavy chain is in gold, and H57 Fab light chain is in purple. The C␤ FG loop, which is the epitope recognized by the mAb H57, is indicated. This loop creates one side wall of a cavity (whose center is marked by the C␤ label) within the TCR Ti ␣ր␤ constant region while the CD (*) and EF (**) loops of the C␣ domain form the other side. The cavity size is sufficient to accommodate a single nonglycosylated Ig domain such as the CD3⑀ chain.
‫%05ف‬ of the normal cell surface level of mouse CD3⑀. However, 2C11 binding affinity to the mouse CD3⑀ subunit is not altered by the presence of the human CD3⑀ component (K d ‫01ف‬ Ϫ8 M). The capacity of the unlabeled 2C11 mAb to block binding of FITC-H57 to heterozygous hCD3⑀tg T cells was also examined. As shown in Fig.  3 B, the same amount of unlabeled 2C11 that blocks FITC-H57 binding to the WT mouse T cells only partially blocks the FITC-H57 binding to hCD3⑀tg T cells. This suggests that the human CD3⑀ subunit can replace the mouse CD3⑀ subunit in agreement with the finding of others (10, 41) , and that it can occupy the cavity within the mouse TCR C␤C␣ module. Fig. 3 B also demonstrates that the incubation of the mouse splenocytes with the 2C11 mAb does not block the binding of H57 to the TCR-␤ chain by downmodulation of the TCR complex from the T cell surface (42, 43) . Thus, unlabeled 2C11 preincubation does not change the binding of the anti V␤8 mAb, FITC-F23.1, to T cells.
The Binding of the H57 mAb to the C␤ FG Loop Is Unaffected by Human Versus Mouse Origin of the CD3⑀ Component.
In contrast to the results comparing mouse CD3⑀ in WT and hCD3⑀tg mice where the level of 2C11 expression is ‫%05ف‬ on the latter (Fig. 3 A) , H57 reactivity is equivalent in both (Fig. 4) .This implies that the affinity of H57 mAb to the C␤ FG loop is not altered by the presence of the human CD3⑀ component. Had human CD3⑀ altered the affinity of H57, then the curves of mFI at different molar concentrations of FITC-H57 would have shown Although the total copy number of the mouse CD3⑀ subunits in hCD3⑀tg T cells is half of that in WT animals, 2C11 mAb only partially blocks the FITC-H57 binding in the hCD3⑀tg mouse (lower center histogram). Note that preincubation of the T cells with 2C11 had no effect on the TCR expression level since the anti-V␤8 mAb binds to a subset of T cells expressing V␤8 as well with or without 2C11 competition (right). a difference in the two mouse strains. Unlabeled 2C11 competitor mAb shifts the binding curve by ‫2ف‬ logs, at concentrations of FITC-H57 below 10 Ϫ6 M. At the highest concentration of FITC-H57 (10 Ϫ6 M), the labeled antibody binds similarly in the presence or absence of unlabeled competitor 2C11 mAb. These finding are consistent with the notion that the epitopes defined by H57 and 2C11 mAbs are distinct but nevertheless partially overlapping.
Discussion
The crystal structure of the complex between the N15 TCR and an Fab fragment of the anti-C␤ mAb H57 led us to the hypothesis that one CD3⑀ may physically associate with the H57 mAb epitope on C␤ (33) . In this paper we demonstrate that one of the two CD3⑀ subunits of the TCR lies adjacent to the C␤ FG loop.
The overall shape of the TCR C domain module is remarkably asymmetric (Fig. 1) . The C␤ domain bends more acutely towards the V␤ domain compared with the angle formed between the C␣ and V␣ domains. C␤ also has an unusually long and well-structured FG loop (the H57 mAb epitope) projecting down from the V␤-C␤ interface in all TCRs studied to date (33, 44, 45) . Although half of the C␤ domain's ABED sheet is surface exposed, it does not make contact with the C␣ domain. As described in detail by Wang et al. (33) , this asymmetry creates a cave-like structure or cavity below the ␤ chain sufficient in size to accommodate a single Ig domain. The partially exposed ABED ␤ sheet of the C␤ domain forms an extensive ceiling. The CD and EF loops of the C␣ domain, along with the glycans attached to C␣N185, C␣N121, and C␤N186 form one side wall, and the FG loop of C␤ and the glycan emanating from C␤N236 form the other side wall of the cavity. The glycans project outward and do not obstruct the cavity. The floor of the cave is presumably formed by the plasma membrane on the T cell surface (33) . It is noteworthy that the accessible surface at the ␣ր␤-TCR cavity contains multiple basic residues.
The murine CD3⑀ subunit consists of 87 residues in the extracellular segment, and has Ig-like characteristics suggesting that this segment can readily fold into a small Ig domain (40) . CD3⑀ is the only CD3 subunit with a nonglycosylated Ig-like ectodomain in the TCR complex of man and mouse (40) . Moreover, the CD3⑀ subunit has twice as many acidic residues as basic ones and is therefore negatively charged (pI ϭ 4.5, whereas the predicted pIs of the CD3␥ and CD3␦ extracellular domains are more basic, being 8.76 and 5.82, respectively). The charge complementation between the acidic residues of the CD3⑀ subunit and the basic cavity also argues in favor of the CD3⑀ subunit occupying this site. The initial hypothesis regarding the proximity of CD3⑀ and the C␤ FG loop was confirmed here by a set of competition assays in which the 2C11 and H57 mAbs, which bind to epitopes on CD3⑀ and TCR-␤, respectively, were able to alter each other's binding capacity. We further showed that although there are two CD3⑀ subunits per TCR-␤ subunit, only one of the CD3⑀ components is in close proximity to the C␤ FG loop. Given that the ␥ր␦-TCR includes CD3 components (46) and is predicted to contain an equivalent insertion in the corresponding constant domain loop (47) analogous to the C␤ FG loop, we can reasonably predict that a cavity with a comparable arrangement for CD3⑀ exists in ␥ր␦ T cells.
If the TCR C module cavity associates with one CD3⑀, where is the second CD3⑀ located? In vitro translation studies have shown that when CD3⑀ is translated alone it tends to form disulfide-linked oligomers. However, using more physiological TCR-␣/␤-CD3 expression conditions, namely simultaneous cotranslation of all the TCR subunits, the cotranslation of CD3␥ or CD3␦ was sufficient to keep CD3⑀ in a monomeric state (48) . Both CD3␥ and CD3␦ compete for binding to CD3⑀ (49) . In addition, it was shown that the CD3␦/⑀ pair associates with TCR-␣, whereas the CD3␥/⑀ pair associates with TCR-␤. This association takes place upon formation of an intrachain disulfide bridge between TCR-␣ and -␤ (10). Additional studies have shown that CD3⑀ and TCR-␤ pair via their ectodomains, whereas the association of the other CD3 components with TCR-␣ and -␤ is largely mediated by interactions within their transmembrane regions. The proximity of TCR-␤ and CD3␥ has been suggested by crosslinking experiments in humans (50) and mice (7) . Based on these findings, it is likely that the CD3⑀ subunit that is physically associated with the C␤ FG loop is paired with CD3␥ and that the second CD3⑀, which pairs with the extracellular domain of the CD3␦ subunit, associates via its transmembrane domain with the TCR-␣ (51). The ability of the CD3⑀ր␥ dimer-specific mAb 7D6 (52) to partially inhibit FITC-H57 binding to T cells is also consistent with this view (data not shown).
An interesting feature of the potential interaction of CD3⑀ within the TCR C domain module relates to certain critical C␣ residues that are preserved in pre-T␣ (pT␣), a 30-kD glycoprotein whose expression is restricted to early CD4 Ϫ CD8 Ϫ DN T lineage cells (53) (54) (55) . The pre-TCR, a disulfide-linked heterodimer of a functionally rearranged TCR-␤ chain and the pT␣ chain, noncovalently associated with the CD3 components is expressed in DN immature thymocytes (56) . During development, the DN to DP thymocyte transition is induced by an as yet unknown ligand that binds to the pre-TCR, resulting in expression of mature type ␣ր␤ TCR heterodimers on DP thymocytes (57) (58) (59) . Although there is only 12% identity between pT␣ and C␣ in humans and mice (60) , the C␣ residues involving important polar interactions with the C␤ domain are all conserved in the pT␣ sequence. Given that conserved structural elements account for close to half of the pT␣-C␣ amino acid sequence identities, it is very obvious that the heterodimer interface of pT␣-C␤ will be extremely similar to that of C␣-C␤. With this in mind and since genetic disruption of the CD3⑀ gene results in T cell development blockage at the DN stage, it is likely that the CD3⑀ subunit is accommodated in the pre-TCR module in a manner similar to its mode in the mature ␣ր␤-TCR.
One can imagine that certain mouse CD3⑀ residues contribute to the contacts made between H57 and the TCR. In this regard, the total buried molecular surface area at the N15 TCR-H57 Fab interaction is 1460A 2 (720A 2 for N15 and 740A 2 for H57) (33) , consistent with the range of values observed for other intact protein antigen-Fab interactions (61) (62) (63) . However, one unusual feature of the N15-H57 interaction is the predominance of contacts made by the light chain (430A 2 buried surface) rather than the heavy chain (310A 2 buried surface) (33) . This unusual characteristic led us to postulate that the mAb H57 heavy chain may interact primarily with TCR C␤ but in addition with some CD3⑀ residues. In agreement with that notion is the large rotational mobility (‫02ف‬Њ) of the Fab relative to the TCR C␤ FG loop observed in the two independent copies of the TCR-Fab complexes in the asymmetric unit of the crystal (33) . Nevertheless, analysis of the hemizygous hCD3⑀tg mice revealed that although those T cells contain only half the surface copy number of the mouse CD3⑀, H57 affinity is unaltered. This result suggests that the assembly of the TCR complex is not affected by the expression of the human CD3⑀, and that the extracellular domain of the human CD3⑀ subunit can fit into the mouse TCR C domain module cavity (Fig. 3 B) . Given that the extracellular domain of the mouse and human CD3⑀ share 53% identity in their amino acid sequence, it is possible that any putative CD3⑀ residues that interact with the H57 heavy chain are conserved among mouse and human CD3⑀.
Although the precise functional role of the FG loop in C␤ is far from clear, it is likely to have an important impact on signaling and/or TCR assembly and structure. The unique FG loop is conserved among sequences of mouse, rat, human, and rabbit TCRs (39) . Although absent in TCRs sequences from some other species, it is replaced by a potential glycosylated addition site whose glycan may serve a similar structural function (33) . Undoubtedly this loop influences the mobility and disposition of V␤ relative to C␤ domains. Although the minihydrophobic patch of this loop as resolved from the crystal structure fixes the overall loop orientation relative to the V␤ and C␤ domains, local movements are permitted (33) . How, if at all, peptide-MHC interactions might transfer information to the CD3 signaling subunits by affecting the FG C␤ loop remains to be tested experimentally.
